Prevalence, characteristics, and impact of adverse events in 34 Madrid hospitals. The ESHMAD study - Valencia-Martín, J.L.; Vicente-Guijarro, J.; San Jose-Saras, D.; Moreno-Nunez, P.; Pardo-Hernández, A.; Aranaz-Andrés, J.M.; Colomer Rosas, A.; Mediavilla Herrera, I.; Esteban Niveiro, M.J.; López Fresneña, N.; Díaz-Agero Pérez, C.; Ruiz Lopez, P.; et al. (European Journal of Clinical Investigation, 2022)